TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: PNRCH    
Drug Immunoassay Panel, Urine

Useful For Suggests clinical disorders or settings where the test may be helpful

Detecting drug use involving amphetamines, barbiturates, cocaine, phencyclidine, and tetrahydrocannabinol

Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.

Test IDReporting NameAvailable SeparatelyAlways Performed
AMPHUAmphetamines Confirmation, UYesNo
BARBUBarbiturates Confirmation, UYesNo
COKEUCocaine and metabolite Conf, UYesNo
PCPUPhencyclidine Confirmation, UYesNo
THCUCarboxy-THC Confirmation, UYesNo

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

Testing begins with screening tests for drugs of abuse including amphetamines, barbiturates, cocaine, phencyclidine, and tetrahydrocannabinol. Positives are confirmed and quantitated by definitive methods (gas chromatography-mass spectrometry for barbiturates, cocaine and metabolites, phencyclidine, and tetrahydrocannabinol metabolite) at an additional charge. Amphetamines that screen positive will be quantified with liquid chromatography-tandem mass spectrometry at an additional charge.

Method Name A short description of the method used to perform the test

Only orderable as part of profile. For more information see CSMP / Controlled Substance Monitoring Panel, Urine.

 

Screened by Immunoassay and Confirmed by Gas Chromatography-Mass Spectrometry (GC-MS) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

Drug Immunoassay Panel, U